Molina Healthcare, Inc. insider trading
Every open-market purchase and sale by Molina Healthcare, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Molina Healthcare, Inc.’s insiders pay?
From March 22, 2010 to May 15, 2026, 35 insiders reported 5 open-market purchases and 197 sales not made under a pre-set plan in Molina Healthcare, Inc. Twelve months after each purchase was reported, the shares were −20.2% against the S&P 500 on average (median −21.0%), over 4 purchases with a full year of prices; 25% beat the index. After sales, the shares moved +2.9% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on March 15, 2013 into $10,863 by November 2, 2026, +0.6% a year. It held shares 31% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $23,157 (+6.4% a year), and held throughout $61,010 (+14.2%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Romney Ronna | Director | 0 | — | — | 20 | +0.8% (19) | March 13, 2026 |
| Orlando Steven J | Director | 0 | — | — | 18 | −16.6% (18) | May 5, 2025 |
| Carruthers Garrey | Director | 0 | — | — | 15 | +19.2% (15) | March 3, 2021 |
| Wolf Dale B | Director | 1 | −12.1% (1) | 0% | 14 | −3.8% (14) | May 22, 2025 |
| Bayer Terry | Chief Operating Officer | 0 | — | — | 13 | +10.1% (13) | August 18, 2015 |
| Cooperman Daniel | Director | 0 | — | — | 12 | +14.4% (12) | March 3, 2023 |
| Murray Frank E Md | Director | 0 | — | — | 12 | +16.5% (12) | August 8, 2016 |
| Barlow Jeff D. | Chief Legal Officer | 0 | — | — | 11 | −3.8% (10) | May 13, 2026 |
| Fedak Charles Z | Director | 0 | — | — | 11 | +17.0% (11) | November 21, 2018 |
| Szabo John P Jr | Director | 0 | — | — | 11 | +12.5% (11) | November 7, 2014 |
| White Joseph W Cpa | Chief Accounting Officer | 0 | — | — | 10 | +1.0% (10) | August 4, 2016 |
| Schapiro Richard M | Director | 1 | −43.4% (1) | 0% | 7 | −40.1% (6) | November 24, 2025 |
| Molina J Mario Md | President & CEO | 0 | — | — | 7 | −3.2% (7) | April 7, 2015 |
| Molina Marital Trust | 10% owner | 0 | — | — | 4 | +0.3% (4) | August 27, 2013 |
| Hebert Maurice | Chief Accounting Officer | 0 | — | — | 3 | −40.7% (2) | May 15, 2026 |
| James Steven | Director | 0 | — | — | 3 | −20.4% (3) | March 11, 2016 |
| Molina John C | CFO | 0 | — | — | 3 | +48.4% (3) | February 20, 2018 |
| Nichols Norman | Other | 0 | — | — | 3 | +15.7% (3) | August 9, 2018 |
| Woys James | Chief Operating Officer | 2 | −12.6% (2) | 50% | 1 | −14.4% (1) | August 6, 2025 |
| Desai Amir | Chief Information Officer | 0 | — | — | 2 | +13.2% (2) | August 17, 2010 |
| Keim Mark Lowell | Chief Financial Officer | 0 | — | — | 2 | −31.0% (2) | February 14, 2024 |
| Richardson Sally K | Director | 0 | — | — | 2 | +15.6% (2) | November 2, 2011 |
| Russo Marc | EVP, Health Plans | 0 | — | — | 2 | −13.6% (2) | August 7, 2023 |
| Andrews Mark L Esq | Chief Legal Officer | 0 | — | — | 1 | +32.7% (1) | March 23, 2010 |
| Bacon Debra | EVP, Medicaid | 0 | — | — | 1 | −51.6% (1) | February 16, 2024 |
| Brasier Barbara L | Director | 0 | — | — | 1 | −4.8% (1) | August 1, 2023 |
| Dentino William | 10% owner | 0 | — | — | 1 | −5.6% (1) | August 7, 2013 |
| Howatt James W | Chief Medical Officer | 0 | — | — | 1 | +32.7% (1) | March 23, 2010 |
| Mary R Molina Living Trust | 10% owner | 0 | — | — | 1 | −1.9% (1) | August 12, 2013 |
| Molina Siblings Trust | CFO | 0 | — | — | 1 | −16.4% (1) | March 5, 2012 |
| Pedersen Curtis | 10% owner | 0 | — | — | 1 | +3.6% (1) | August 22, 2013 |
| Rubino Lisa A | Senior Vice President | 0 | — | — | 1 | +111.5% (1) | August 21, 2017 |
| Tran Thomas L | Other | 0 | — | — | 1 | +28.1% (1) | May 24, 2021 |
| Zoretic Richard C | Director | 1 | — | — | 0 | — | February 12, 2026 |
| Zubretsky Joseph M | President & CEO | 0 | — | — | 1 | −70.0% (1) | May 2, 2025 |
When several insiders traded Molina Healthcare, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Molina Healthcare, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 24 selling crowds, −3.5%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| May 29, 2026 | 3 selling | +13.2% | not yet | not yet |
| May 30, 2025 | 4 selling | −50.5% | −68.0% | −71.4% |
| July 31, 2024 | 3 selling | −11.3% | −19.0% | −69.7% |
| February 29, 2024 | 5 selling | −25.5% | −21.6% | −37.2% |
| August 31, 2023 | 4 selling | +16.2% | +10.0% | −9.5% |
| August 31, 2022 | 4 selling | −3.8% | −20.0% | −24.0% |
| March 31, 2022 | 3 selling | 0.0% | +19.1% | −11.0% |
| May 28, 2021 | 5 selling | −0.6% | +6.4% | +21.2% |
| November 30, 2020 | 5 selling | −1.9% | +5.0% | +12.1% |
| August 31, 2018 | 5 selling | +5.9% | −2.7% | −14.3% |
| November 30, 2017 | 4 selling | −8.5% | +3.9% | +72.7% |
| May 31, 2017 | 3 selling | −3.6% | +6.2% | +17.2% |